A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)

Clinical trial NCT01023724 · COMPLETED

Trial details

NCT number: NCT01023724
Sponsor: Bucci Laser Vision Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Post Operative Anterior Chamber Inflammation (Flare)

Start date: 2009-12-01
Primary completion: 2010-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.